Skip to main content
Clinical Trials/NL-OMON30469
NL-OMON30469
Completed
Phase 3

A randomized trial in cancer-related fatigue in palliatively treated patients: protocolized patient-tailored treatment of physical symptoms (PPT) vs care as usual (CAU) - Cancer-related fatigue: systematic treatment of physical symptoms

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
152
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • a. Histologically or cytologically proven solid malignancy;
  • b. Curative treatment is not possible anymore;
  • c. Treated in the outpatient clinic;
  • d. Presence of fatigue scored as \>\=4 on a scale of 0 to 10;
  • e. Age \>\=18 years;
  • f. WHO performance status \<\= 2;
  • g. Life expectancy \>\= 3 months;
  • h. Able to write and speak Dutch;
  • i. Signed informed consent.

Exclusion Criteria

  • a. Concomitant (or within 4 weeks before randomization) administration
  • of any experimental drug;
  • b. Stay in a nursing home;
  • c. Untreated depression or anxiety disorders;
  • d. Severe comorbidity, e.g. heart failure or symptomatic chronic obstructive
  • lung disease
  • e. Cognitive limitations

Outcomes

Primary Outcomes

Not specified

Similar Trials